Key facts
- It has raised $930K; the latest was Early Stage VC ($930K) in Sep 2025.
- Notable investors include Aggir Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Deepful
- ·The full record, as it builds
Funding rounds
No funding rounds for Deepful are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Deepful
Developer of AI-driven simulation software designed for pharmaceutical sales and medical science liaison training. The company's platform offers customizable role-play scenarios with localized content, integrates scientific visuals and pharma-specific KPIs, generates structured performance reports, and provides real-time dashboards for coaching and trend analysis, enabling pharmaceutical organizations to enhance onboarding, refine messaging, and improve commercial effectiveness.
- Sector
- Information Technology
- HQ
- Barcelona, Spain
- Founded
- 2023
- Employees
- 16
- Website
- deepful.ai/
- Ownership
- Privately Held (backing)
Deepful doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Deepful shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Deepful in its N-PORT filings yet. We sweep new filings monthly.